<prompt> Please answer with one of the option in the bracket. Write reasoning in between . Write answer in between .Q:A 73-year-old female presents to you for an office visit with complaints of getting lost. The patient states that over the last several years, the patient has started getting lost in places that she is familiar with, like in her neighborhood while driving to her church. She has also has difficulty remembering to pay her bills. She denies any other complaints. Her vitals are normal, and her physical exam does not reveal any focal neurological deficits. Her mini-mental status exam is scored 1930. Work up for secondary causes of cognitive decline is negative. Which of the following should be included in the patients medication regimen to slow the progression of disease?? A: Ropinirole, B: Memantine, C: Bromocriptine, D: Pramipexole, E: Pergolide,  <response>: This is a patient case about a 73-year-old woman presenting with progressive cognitive impairment and memory issues concerning for Alzheimers dementia. The history and exam are consistent with Alzheimers dementia. The question asks about which medication should be included to slow the progression of the disease. Based on the patients presentation, the correct medication class would be an NMDA receptor antagonist like memantine. Ropinirole, bromocriptine, pramipexole and pergolide are dopamine agonists used for Parkinsons disease, not Alzheimers dementia.B: Memantine 